These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6389600)
1. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. Yahalom J; Eldor A; Fuks Z; Vlodavsky I J Clin Invest; 1984 Nov; 74(5):1842-9. PubMed ID: 6389600 [TBL] [Abstract][Full Text] [Related]
2. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275 [TBL] [Abstract][Full Text] [Related]
3. Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. Yahalom J; Eldor A; Biran S; Fuks Z; Vlodavsky I Radiother Oncol; 1985 Apr; 3(3):211-25. PubMed ID: 4001443 [TBL] [Abstract][Full Text] [Related]
7. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586 [TBL] [Abstract][Full Text] [Related]
8. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides. Oldberg A; Heldin CH; Wasteson A; Busch C; Höök M Biochemistry; 1980 Dec; 19(25):5755-62. PubMed ID: 7459342 [TBL] [Abstract][Full Text] [Related]
10. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Bashkin P; Razin E; Eldor A; Vlodavsky I Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299 [TBL] [Abstract][Full Text] [Related]
11. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287 [TBL] [Abstract][Full Text] [Related]
12. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Vlodavsky I; Fuks Z; Bar-Ner M; Ariav Y; Schirrmacher V Cancer Res; 1983 Jun; 43(6):2704-11. PubMed ID: 6601984 [TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764 [TBL] [Abstract][Full Text] [Related]
14. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. Benezra M; Vlodavsky I; Bar-Shavit R Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820 [TBL] [Abstract][Full Text] [Related]
16. Subendothelial extracellular-matrix heparan sulfate proteoglycan-degrading activity of human monocyte macrophages. Shimada K; Ozawa T Heart Vessels; 1987; 3(4):175-81. PubMed ID: 2969381 [TBL] [Abstract][Full Text] [Related]